RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Curevo Vaccine

Curevo Vaccine

Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market quickly.

Latest funding

Series B+ ·

Amount not disclosed in a source on record.

All 3 rounds ↓

Acquired by EEli Lilly on for $1.5B · Seattle Times.

LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Health Care, Medical.
Stage: Series B+.
Based in: Bothell, United States.
Last round: Mar 18, 2025 · 608 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredDec 18, 2017 (8 years old)
TIMELINE · MILESTONES

Curevo Vaccine | 1740 days on the record

3 rounds
MARNOVJULMARNOVJULMARNOVSeries A · Feb 10, 2022A · FEB '22Series A · Nov 17, 2022A · NOV '22Series B+ · Mar 18, 2025B+ · MAR '25Acquired by Eli Lilly · May 26, 2026ACQUIRED BY ELI LILLY · MAY '26

One step per dated milestone. Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+undisclosed—fundraisingfox.com
Series Aundisclosed—flgpartners.com
Series AundisclosedRRA Capital Managementbusinesswire.com

Timeline

  1. Acquired by EEli Lilly · $1.5B
  2. Website created

Team

Investors

Companies like Curevo Vaccine

Other companies backed by RA Capital Management

RA Capital Management portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/curevo-vaccine (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy